rs11206510

23andMe blog coronary artery disease and heart attack SNP Risk Version Effect *rs646776 T 1.19 *rs17465637 C 1.14 *rs1746048 C 1.17 *rs6725887 C 1.17 *rs11206510 T 1.15 *rs3184504 T 1.13 *rs2306374 C 1.15 *rs3782886 C 1.44 Carriers of a 'protective' rs11206510(C) allele benefit from a lower risk (0.84x) of nonfatal myocardial infarction by taking long-chain (LC) n-3 (ω-3) polyunsaturated fatty acids (PUFAs), whereas noncarriers show no such benefit, based on a study of ~4000 individuals living in Costa Rica. Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. Genetics of diabetes complications. Using a latent growth curve model for an integrative assessment of the effects of genetic and environmental factors on multiple phenotypes. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Genetics of coronary artery disease: focus on genome-wide association studies. Analysis of recently identified dyslipidemia alleles reveals two loci that contribute to risk for carotid artery disease. Genome-wide association studies for atherosclerotic vascular disease and its risk factors. Common lipid-altering gene variants are associated with therapeutic intervention thresholds of lipid levels in older people. Loci influencing lipid levels and coronary heart disease risk in 16 European population cohorts. Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. Metabolic and cardiovascular traits: an abundance of recently identified common genetic variants. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans.